Pentavalent Market Report 2026

Pentavalent Market Overview

• Pentavalent market size has reached to $2.7 billion in 2025 • Expected to grow to $3.39 billion in 2030 at a compound annual growth rate (CAGR) of 4.7% • Growth Driver: Pentavalent Market Surges With Increasing Diphtheria Incidence • Market Trend: Companies Spearhead Innovation With Pentavalent Immunization Solutions • Asia-Pacific was the largest region in 2025.

What Is Covered Under Pentavalent Market?

Pentavalent refers to a vaccine that protects a child from life-threatening diseases. This vaccine is used to protect infants and young children from rotavirus infection. Rotavirus infection can result in fever, vomiting, and diarrhea. It is administered to infants as part of routine immunization programs and is used to provide broad, early protection against major infectious diseases in children. The main types of pentavalent vaccine are sodium stibogluconate, meglumine antimoniate. Lyophilization refers to a method of removing water that is frequently used to preserve perishable products, increase shelf life, or make the substance easier to transport. The various formulation types include lyophilized and liquid. These ate used in various applications such as hospitals pharmacies, retail pharmacies, and online pharmacies.

What Is The Pentavalent Market Growth Forecast?

The pentavalent market size is expected to see steady growth in the next few years. It will grow to $3.39 billion in 2030 at a compound annual growth rate (CAGR) of 4.7%. The growth in the forecast period can be attributed to technological advancements in vaccine formulation, increasing healthcare expenditure, expansion of immunization programs in developing countries, partnerships between pharma companies, integration of digital tracking for vaccine coverage. Major trends in the forecast period include increased infant immunization programs, government funding for vaccine development, expansion of public health infrastructure, rising awareness of rotavirus prevention, growth of cold chain logistics.

Global Pentavalent Market Segmentation

1) By Type: Pentavalent Vaccines (DTP-HepB-Hib combination), Other Combination Vaccines 2) By Formulation Type: Lyophilized, Liquid 3) By Application: Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies Subsegments: 1) By Pentavalent Vaccines (DTP-HepB-Hib combination): DTP-HepB-Hib (Whole Cell), DTP-HepB-Hib (Acellular) 2) By Other Combination Vaccines: Hexavalent Vaccines

What Are The Drivers Of The Pentavalent Market?

The rising prevalence of diphtheria is expected to boost the growth of the pentavalent market going forward. Corynebacterium diphtheriae is a bacterium that causes the severe, extremely contagious disease known as diphtheria. Diphtheria causes severe difficulties with eating and breathing, as well as the possibility of skin ulcers. The pentavalent vaccine protects children from Diphtheria diseases by a pentavalent immunization in a 3-dose schedule, as a result, the rising prevalence of diphtheria increased the demand for pentavalent vaccines. For instance, in July 2025, according to the European Centre for Disease Prevention and Control, a Europe-based government agency, in Germany a total of 126 laboratory-confirmed cases of C. diphtheriae ST574 have been identified across the country with 55 cases in 2022, 49 cases in 2023, 18 cases in 2024 and at least 4 cases in 2025. Therefore, the rising prevalence of diphtheria is driving the growth of the pentavalent industry. The rising healthcare expenditure is expected to boost the growth of the pentavalent market going forward. Healthcare expenditure refers to the total amount of resources, including money and other resources, spent on the provision of healthcare services within a specific time period. Healthcare expenditure in the context of pentavalent are the financial resources allocated for the development, production, distribution, and administration of vaccines that protect against five different targeted diseases. For instance, in December 2024, according to the Centers for Medicare & Medicaid Services, a US-based agency responsible for administering the Medicare and Medicaid programs, in 2023, U.S. health care expenditures increased by 7.5%, climbing to $4.9 trillion, or roughly $14,570 for each individual. Therefore, the rising healthcare expenditure is driving the growth of the pentavalent industry.

Key Players In The Global Pentavalent Market

Major companies operating in the pentavalent market are Pfizer Inc., Merck & Co Inc., Sanofi SA, GlaxoSmithKline plc, Shandong Xinhua Pharmaceutical Company Limited, PT Bio Farma (Persero), Shantha Biotechnics Limited, Biological E. Limited, Serum Institute of India Private Limited, Indian Immunologicals Limited, Incepta Pharmaceuticals Limited, Shanghai Institute of Biological Products Co Ltd., Changchun Changsheng Biotechnology Co Ltd., Adimmune Corporation, AJ Vaccines, Albert David Limited, PanGen Biotech Inc., Bharat Biotech International Limited, Vacsera Ltd., Pasteur Institute of India, Zydus Cadila Healthcare Limited, EuBiologics Co Ltd.

Global Pentavalent Market Trends and Insights

Major companies operating in the pentavalent market are focused on developing innovative solutions such as pentavalent immunization vaccines. Pentavalent immunization vaccines are a type of combination vaccine designed to protect against five different diseases. For instance, in October 2023, Pfizer, a US-based pharmaceutical company announced the FDA approval for its ‘Penbraya’ pentavalent vaccine. It is the initial and sole pentavalent vaccine providing protection against the five most prevalent meningococcal serogroups namely A, B, C, W-135, and Y in individuals aged 10 through 25 years. The vaccine merges elements from the Trumenba meningococcal group B vaccine and the Nimenrix meningococcal groups A, C, W-135, and Y conjugate vaccine. Penbraya has been identified as effective in providing protection against the five meningococcal serogroups responsible for the majority of global cases of invasive meningococcal disease.

Regional Insights

Asia-Pacific was the largest region in the pentavalent market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Pentavalent Market?

The pentavalent market consists of sales of pentavalent vaccines such as those for diphtheria, pertussis, tetanus, hepatitis B, and Hib that treat a child against potentially fatal diseases. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Pentavalent Market Report 2026?

The pentavalent market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pentavalent industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.